Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Solesence (SLSN) Research & Development (2016 - 2025)

Solesence (SLSN) has disclosed Research & Development for 16 consecutive years, with $1.1 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Research & Development rose 11.55% year-over-year to $1.1 million, compared with a TTM value of $4.1 million through Sep 2025, up 17.48%, and an annual FY2024 reading of $3.8 million, changed 0.0% over the prior year.
  • Research & Development was $1.1 million for Q3 2025 at Solesence, up from $955000.0 in the prior quarter.
  • Across five years, Research & Development topped out at $1.1 million in Q4 2024 and bottomed at $499000.0 in Q1 2021.
  • Average Research & Development over 5 years is $842052.6, with a median of $864000.0 recorded in 2024.
  • The sharpest move saw Research & Development soared 56.79% in 2021, then decreased 12.82% in 2024.
  • Year by year, Research & Development stood at $565000.0 in 2021, then increased by 28.5% to $726000.0 in 2022, then rose by 8.13% to $785000.0 in 2023, then skyrocketed by 38.98% to $1.1 million in 2024, then dropped by 0.82% to $1.1 million in 2025.
  • Business Quant data shows Research & Development for SLSN at $1.1 million in Q3 2025, $955000.0 in Q2 2025, and $1.0 million in Q1 2025.